Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/13028
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKortenkamp, A-
dc.contributor.authorBourguignon, J-P-
dc.contributor.authorSlama, R-
dc.contributor.authorBergman, Å-
dc.contributor.authorDemeneix, B-
dc.contributor.authorIvell, R-
dc.contributor.authorPanzica, G-
dc.contributor.authorTrasande, L-
dc.contributor.authorZoeller, RT-
dc.date.accessioned2016-07-29T11:08:28Z-
dc.date.available2016-07-
dc.date.available2016-07-29T11:08:28Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Diabetes & Endocrinology, 4(8): pp.649–650, (2016)en_US
dc.identifier.issn2213-8587-
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S2213858716301516-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/13028-
dc.description.abstractThe European Commission (EC) has missed a unique opportunity to develop a regulatory system that sets new standards in the protection against endocrine-disrupting chemicals. The proposed amendments to the European Union (EU) pesticide law and the criteria for the identification of endocrine disruptors that the EC published on June 15, 2016, after a delay of almost 3 years,1 ensure that hardly any endocrine disruptors used as pesticides will be barred from commerce.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.titleEU regulation of endocrine disruptors: a missed opportunityen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1016/S2213-8587(16)30151-6-
dc.relation.isPartOfThe Lancet Diabetes & Endocrinology-
pubs.publication-statusPublished-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf97.91 kBUnknownView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.